Most GLP-1 patients find this easier anyway because appetite is reduced, but it requires some deliberate adjustment in the first few weeks
70 Kristensen SL, Rorth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al
Published in JAMA Neurology, the study highlights the potential of GLP-1 RA therapy as an alternative approach to managing this challenging neurological condition
While both treatments are generally safe on their own, combining them can raise certain concerns
Weve broken down what the latest TRIUMPH-2 and TRIUMPH-3 data means, what was actually measured, and why these results matter for researchers following the next generation of GLP-1 science
Such practices are essential to ensure patient safety and well-being while navigating the complexities of obesity management and its potential psychiatric implications